Altman Peter's most recent trade in BioCardia Inc. was a trade of 24,096 Common Stock done at an average price of $2.1 . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.07 per share. | 30 Jun 2025 | 24,096 | 165,862 (2%) | 0% | 2.1 | 49,999 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 30 Jun 2025 | 24,096 | 95,612 | - | - | Warrant (right to buy) | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 30 May 2025 | 100 | 141,766 (2%) | 0% | 2.2 | 221 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.08 per share. | 20 May 2025 | 1,600 | 140,966 (2%) | 0% | 2.1 | 3,328 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.89 per share. | 20 May 2025 | 700 | 141,666 (2%) | 0% | 1.9 | 1,323 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.43 per share. | 14 May 2025 | 300 | 139,366 (2%) | 0% | 2.4 | 730 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 14 May 2025 | 100 | 139,066 (2%) | 0% | 3.0 | 299 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.91 per share. | 23 Apr 2025 | 26,246 | 138,966 (2%) | 0% | 1.9 | 49,999 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 23 Apr 2025 | 26,246 | 71,516 | - | - | Warrant (right to buy) | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.14 per share. | 15 Apr 2025 | 100 | 112,720 (1%) | 0% | 2.1 | 214 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.99 per share. | 10 Apr 2025 | 300 | 112,320 (1%) | 0% | 2.0 | 597 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.03 per share. | 10 Apr 2025 | 300 | 112,620 (1%) | 0% | 2.0 | 609 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.96 per share. | 07 Apr 2025 | 500 | 112,020 (1%) | 0% | 2.0 | 980 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.04 per share. | 04 Apr 2025 | 800 | 111,520 (1%) | 0% | 2.0 | 1,632 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 03 Apr 2025 | 1,200 | 109,620 (1%) | 0% | 2.2 | 2,688 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 02 Apr 2025 | 600 | 110,720 (1%) | 0% | 2.2 | 1,320 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.23 per share. | 02 Apr 2025 | 500 | 110,120 (1%) | 0% | 2.2 | 1,115 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.11 per share. | 03 Mar 2025 | 500 | 108,420 (1%) | 0% | 2.1 | 1,055 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.48 per share. | 07 Feb 2025 | 600 | 107,920 (1%) | 0% | 2.5 | 1,488 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.40 per share. | 29 Jan 2025 | 500 | 107,081 (1%) | 0% | 2.4 | 1,200 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 29 Jan 2025 | 239 | 107,320 (1%) | 0% | 2.4 | 569 | Common Stock |
| BioCardia Inc. | Altman Peter | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 23 Dec 2024 | 1,000 | 106,581 (1%) | 0% | 2.1 | 2,060 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.22 per share. | 05 Dec 2024 | 250 | 105,581 (1%) | 0% | 2.2 | 555 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 15 Nov 2024 | 1,350 | 105,331 (1%) | 0% | 1.9 | 2,525 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.65 per share. | 11 Oct 2024 | 44,250 | 125,661 (1%) | 0% | 2.7 | 117,263 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 11 Oct 2024 | 21,680 | 103,981 (1%) | 0% | 2.7 | 57,452 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 3.00 per share. | 03 Sep 2024 | 41,666 | 81,411 (1%) | 0% | 3 | 124,998 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 41,666 | 41,666 | - | - | Warrant (right to buy) | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.05 per share. | 28 Jun 2024 | 300 | 39,745 (0%) | 0% | 3.1 | 915 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 28 Jun 2024 | 200 | 39,445 (0%) | 0% | 3.0 | 598 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.29 per share. | 21 Jun 2024 | 500 | 39,245 (0%) | 0% | 3.3 | 1,645 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.52 per share. | 14 Jun 2024 | 500 | 38,745 (0%) | 0% | 3.5 | 1,760 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.36 per share. | 10 Jun 2024 | 1,000 | 38,245 (0%) | 0% | 3.4 | 3,360 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 19 Apr 2024 | 2,750 | 558,697 (8%) | 0% | 0.4 | 1,013 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 28 Mar 2024 | 500 | 555,947 (8%) | 0% | 0.4 | 195 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.46 per share. | 13 Feb 2024 | 108,108 | 555,447 (8%) | 1% | 0.5 | 50,000 | Common Stock |
| BioCardia Inc. | Altman Peter | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Feb 2024 | 54,054 | 121,538 | - | - | Warrant (right to buy | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 17 Aug 2023 | 4,000 | 447,339 (6%) | 0% | 0.9 | 3,484 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 14 Aug 2023 | 4,500 | 443,339 (6%) | 0% | 0.9 | 3,978 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 2.34 per share. | 23 Jun 2023 | 6,421 | 438,839 (6%) | 0% | 2.3 | 14,999 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.77 per share. | 31 May 2023 | 36,821 | 432,418 (6%) | 0% | 1.8 | 65,173 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 26 May 2023 | 6,200 | 469,239 (6%) | 0% | 1.6 | 9,920 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 159,723 | 159,723 | - | - | Stock Option (right to buy) | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.70 per share. | 18 May 2023 | 109,324 | 463,039 (6%) | 1% | 1.7 | 185,851 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.68 per share. | 16 Dec 2022 | 14,880 | 347,827 (5%) | 0% | 1.7 | 24,998 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 10 Nov 2022 | 3,100 | 331,547 (4%) | 0% | 1.9 | 5,797 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.86 per share. | 10 Nov 2022 | 1,400 | 332,947 (4%) | 0% | 1.9 | 2,604 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.81 per share. | 22 Sep 2022 | 3,100 | 327,047 (4%) | 0% | 1.8 | 5,611 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 22 Sep 2022 | 1,400 | 328,447 (4%) | 0% | 1.9 | 2,618 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.92 per share. | 21 Sep 2022 | 2,750 | 323,947 (4%) | 0% | 1.9 | 5,280 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.46 per share. | 10 Jun 2022 | 4,500 | 321,197 (4%) | 0% | 1.5 | 6,570 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 12 May 2022 | 31,446 | 316,697 (4%) | 0% | 1.3 | 41,509 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 11 May 2022 | 11,302 | 345,445 (5%) | 0% | 1.2 | 13,562 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 11 May 2022 | 2,698 | 348,143 (5%) | 0% | 1.4 | 3,723 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 11 May 2022 | 1,000 | 334,143 (4%) | 0% | 1.3 | 1,300 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.61 per share. | 28 Apr 2022 | 2,700 | 333,143 (4%) | 0% | 1.6 | 4,347 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.59 per share. | 28 Apr 2022 | 2,300 | 330,443 (4%) | 0% | 1.6 | 3,657 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 141,000 | 141,000 | - | - | Stock Option (right to buy) | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2022 | 76,734 | 314,643 (4%) | 1% | 0 | Common Stock | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 14 Apr 2022 | 13,500 | 328,143 (4%) | 0% | 1.4 | 18,700 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 18 Nov 2021 | 5,000 | 237,909 (3%) | 0% | 2.2 | 11,000 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.94 per share. | 17 Aug 2021 | 3,500 | 232,909 (3%) | 0% | 2.9 | 10,290 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.35 per share. | 10 Jun 2021 | 11,572 | 229,409 (3%) | 0% | 4.3 | 50,338 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2021 | 177,470 | 177,470 | - | - | Stock Option (right to buy) | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2021 | 33,581 | 240,981 (3%) | 0% | 0 | Common Stock | |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.31 per share. | 27 Nov 2020 | 3,200 | 203,200 (2%) | 0% | 2.3 | 7,380 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.37 per share. | 27 Nov 2020 | 3,200 | 206,400 (3%) | 0% | 2.4 | 7,580 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.49 per share. | 27 Nov 2020 | 1,000 | 207,400 (3%) | 0% | 2.5 | 2,488 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 12 Nov 2020 | 2,000 | 205,900 (3%) | 0% | 2.1 | 4,130 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.09 per share. | 12 Nov 2020 | 500 | 206,400 (3%) | 0% | 2.1 | 1,046 | Common Stock |
| BioCardia Inc. | Peter Altman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.98 per share. | 10 Nov 2020 | 2,500 | 203,900 (2%) | 0% | 2.0 | 4,950 | Common Stock |